Profile
Footprint with customer proximitySix cGMP-certified sites on three continents1
Helping patients across multiple health indicationsRevenue from across therapeutic areas with pharma and biotech customers
Solutions for development and commercial products“Start here – stay here”
1 Data based on headcount as at 31 December 2022.
2 Approximate splits as per 31 December 2022.
3 Subsequent to the reporting period, one phase III project related to the treatment of cancer was terminated by the customer.
Business modelProviding expert knowledge for peptide- and oligonucleotide-based APIs along the entire life cycle
API – Active Pharmaceutical Ingredient; CMC – Chemistry, Manufacturing & Controls; cGMP – current Good Manufacturing Practice; ICH – International Council for Harmonization; LCM – Life Cycle Management; NDA – New Drug Application; PPQ – Process Performance Qualification.
Integrated strategyStriving to be the preferred long-term partner for customers
